This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Craene, B. A.
Right arrow Articles by De Leenheer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Craene, B. A.
Right arrow Articles by De Leenheer, P.

 Previous Article  |  Next Article 

Antimicrob. Agents Chemother., 09 1997, 1991-1995, Vol 41, No. 9
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves

BA de Craene, P Deprez, E D'Haese, HJ Nelis, W Van den Bossche and P De Leenheer
Laboratorium voor Farmaceutische Microbiologie, Universiteit, Gent, Ghent, Belgium.

Florfenicol, a fluorinated analog of thiamphenicol, is of great value in veterinary infectious diseases that formerly responded favorably to chloramphenicol. In view of the treatment of meningitis in calves, we studied its pharmacokinetics in the cerebrospinal fluid (CSF) and plasma of six animals. To this end, a new high-performance liquid chromatography method was developed which, unlike previous ones, uses solid-phase instead of double-phase extraction to isolate the drug. After a single intravenous dose of 20 mg/kg of body weight, a maximum concentration in CSF of 4.67 +/- 1.51 microg/ml (n = 6) was reached, with a mean residence time of 8.7 h. The decline of florfenicol in both CSF and plasma fitted a biexponential model with elimination half-lives of 13.4 and 3.2 h, respectively. Florfenicol penetrated well into CSF, as evidenced from an availability of 46% +/- 3% relative to plasma. The levels remained above the MIC for Haemophilus somnus over a 20-h period. Our results provide evidence indicating the effectiveness of florfenicol in the treatment of bacterial meningitis of calves.


This article has been cited by other articles:

  • Abeysekara, S., Naylor, J. M., Wassef, A. W. A., Isak, U., Zello, G. A. (2007). D-Lactic acid-induced neurotoxicity in a calf model. Am. J. Physiol. Endocrinol. Metab. 293: E558-E565 [Abstract] [Full Text]  
  • Liu, J., Fung, K.-F., Chen, Z., Zeng, Z., Zhang, J. (2003). Pharmacokinetics of Florfenicol in Healthy Pigs and in Pigs Experimentally Infected with Actinobacillus pleuropneumoniae. Antimicrob. Agents Chemother. 47: 820-823 [Abstract] [Full Text]